Ask a Question

Ask your question and our customer service team will answer it as soon as they can. Questions that do not contain personal information may be posted to our help center to be of service to others.

* Required field

Your Email Address *

Please enter valid email address.

Choose a Topic *

Tell us your question and any additional information *

Please enter all required field.

Please Log In/Join Now first, and then use this function!

Find a Clinical Trials

Researching Lung Cancer

Lung cancer starts when cells of the lung become abnormal and begin to grow out of control

Lung Cancer Clinical Trials

Lung Cancer Clinical Trials

We are currently investigating experimental medications for Non-small cell lung cancer (NSCLC)

Non-small cell lung cancer (NSCLC) accounts for about 85–90% of Lung Cancer diagnoses and is composed of 3 subtypes: squamous cell (epidermoid) carcinoma, adenocarcinoma and large cell (undifferentiated) carcinoma.

Answer a few questions below to see if there are clinical trials that might be right for you.

Thank you for Considering a Clinical Trial

Below you will find clinical trials that are either currently recruiting patients (noted as Recruiting) or starting to recruit patients soon (noted as Not Yet Recruiting).

Here are some options for you to find more information:

Browse the trials available on your own and Click on View Trial Details for more information, including locations that are recruiting patients.
Let us help you find a trial: Pre-Screen Now and answer a few questions to determine if there is a trial that might be right for you.

Non-small Cell Lung Cancer (Advanced Or Recurrent)

CA209-722

Recruiting

A Study of Nivolumab + Chemotherapy or Nivolumab + Ipilimumab Versus Chemotherapy in Patients With EGFR Mutation, T790M Negative NSCLC Who Have Failed 1L EGFR TKI Therapy

View Trial Detail

CA209-817

Recruiting

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

View Trial Detail

CA209-592

Recruiting

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

View Trial Detail

CA209-907

Recruiting

Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer

View Trial Detail

CA209-9LA

Recruiting

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

View Trial Detail

CA209-8KX

Recruiting

A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)

View Trial Detail

Non-small Cell Lung Cancer (Early Stage)

CA209-816

Recruiting

A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)

View Trial Detail

CA209-227

Recruiting

An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

View Trial Detail

CA209-817

Recruiting

An Investigational Immuno-therapy Study for Safety of Nivolumab in Combination With Ipilimumab to Treat Advanced Cancers

View Trial Detail

CA209-816

Recruiting

A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)

View Trial Detail

CA209-9LA

Recruiting

A Study of Nivolumab and Ipilimumab Combined With Chemotherapy Compared to Chemotherapy Alone in First Line NSCLC

View Trial Detail

Get updates on lung cancer clinical trials

Get notified when new studies open that might be right for you

Have questions? Email Us

Have questions?

Email Us